Skip to main content
Log in

Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7)

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Recent studies have described an increase in the incidence of complicated pneumonia in children, primarily caused by Streptococcus pneumoniae. The objective of this study was to determine if the incidence of complicated pneumonias in total and due to different pneumococcal serotypes has changed following the introduction of routine immunization with heptavalent pneumococcal conjugate vaccine (PCV7). A retrospective review of patients admitted to the Stollery Children’s Hospital in Edmonton, Alberta with complicated pneumonia between July 1, 1997 and June 30, 2007 (5 years before and after the introduction of PCV7) was completed. There were 34 children in the pre- and 68 in the post-PCV7 era (14.31 and 19.91 per 10,000 discharges, respectively, p = 0.114). Patient characteristics were not significantly different, and pneumococcus was the most common organism isolated (pre: 21% (7/34); post: 26% (18/68), p = 0.515). In patients where serotype data was available, non-vaccine pneumococcal serotypes accounted for 67% (12/18) cases in the post-PVC7 era versus 14% (1/7) in the pre-PCV7 era (p = 0.031). The incidence of non-vaccine serotypes was 0.42 and 3.51 per 10,000 discharges in the pre- and post-PCV7 eras, respectively (p = 0.020). There has been a non-significant trend towards an increase in the incidence of complicated pneumonia following the introduction of PCV7. S. pneumoniae remains the predominant organism identified with non-vaccine serotypes now accounting for almost all cases. Although it is not clear if this increase is attributable to the use of PCV7, expanding pneumococcal serotype coverage has the potential to prevent complicated pneumonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Advisory Committee on Immunization Practices (2000) Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49(RR-9):1–35

    Google Scholar 

  2. Alberta Health and Wellness Website on Immunizations. http://www.health.gov.ab.ca/public/immunization.html. Accessed July 2008

  3. Ampofo K, Bender J, Sheng X et al (2008) Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 122(2):229–237

    Article  PubMed  Google Scholar 

  4. Buckingham SC, King MD, Miller ML (2003) Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J 22(6):499–504

    Article  PubMed  Google Scholar 

  5. Byington CL, Korgenski K, Daly J et al (2006) Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 25(3):250–254

    Article  PubMed  Google Scholar 

  6. Byington CL, Samore MH, Stoddard GJ et al (2005) Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41(1):21–29

    Article  PubMed  Google Scholar 

  7. Byington CL, Spencer LY, Johnson TA et al (2002) An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 34(4):434–440

    Article  PubMed  Google Scholar 

  8. Centers for Disease Control and Prevention (CDC) (2009) Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine—United States, 1997–2006. MMWR Morb Mortal Wkly Rep 58(1):1–4

    Google Scholar 

  9. Centers for Disease Control and Prevention (CDC) (2008) Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction—eight states, 1998–2005. MMWR Morb Mortal Wkly Rep 57(6):144–148

    Google Scholar 

  10. Dagan R (2009) Serotype replacement in perspective. Vaccine 27(Suppl 3):C22–C24

    Article  CAS  PubMed  Google Scholar 

  11. Fletcher M, Leeming J, Cartwright K et al (2006) Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 25(6):559–560

    Article  PubMed  Google Scholar 

  12. Goldbart AD, Leibovitz E, Porat N et al (2009) Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine. Scand J Infect Dis 41(3):182–187

    Article  PubMed  Google Scholar 

  13. Harboe ZB, Benfield TL, Valentiner-Branth P et al (2010) Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 50(3):329–337

    Article  PubMed  Google Scholar 

  14. Hendrickson DJ, Blumberg DA, Joad JP et al (2008) Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 27(11):1030–1032

    Article  PubMed  Google Scholar 

  15. Hicks LA, Harrison LH, Flannery B et al (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 196:1346–1354

    Article  PubMed  Google Scholar 

  16. Jansen AG, Sanders EA, van der Ende A et al (2008) Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncitial virus activity. Epidemiol Infect 136(11):1448–1454

    Article  CAS  PubMed  Google Scholar 

  17. Karlowsky JA, Lagacé-Wiens PR, Low DE et al (2009) Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005. Int J Antimicrob Agents 34(4):375–379

    Article  CAS  PubMed  Google Scholar 

  18. Kellner JD, Vanderkooi OG, MacDonald J et al (2009) Changing epidemiology of invasive pneumococcal disease in Canada, 1998–2007: update from the Calgary area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 49(2):205–212

    Article  PubMed  Google Scholar 

  19. Langley JM, Kellner J, Solomon N et al (2008) Empyema associated with community-acquired pneumonia: a Pediatric Investigator’s Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis 8:129

    Article  PubMed  Google Scholar 

  20. Li ST, Tancredi DJ (2010) Empyema hospitalizations increased in US despite pneumococcal conjugate vaccine. Pediatrics 125(1):26–33

    Article  PubMed  Google Scholar 

  21. Rees JH, Spencer DA, Parikh D et al (1997) Increase in incidence of childhood empyema in West Midlands, UK. The Lancet 349:402–404

    Article  CAS  Google Scholar 

  22. Rennels MB, Edwards KM, Keyserling HL et al (1998) Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 101:604–611

    Article  CAS  PubMed  Google Scholar 

  23. Schultz KD, Fan LL, Pinsky J et al (2004) The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113(6):1735–1740

    Article  PubMed  Google Scholar 

  24. Tan TQ, Mason EO Jr, Wald ER et al (2002) Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110(1 Pt 1):1–6

    Article  PubMed  Google Scholar 

  25. Tarrago D, Fenoll A, Sanchez-Tatay D et al (2008) Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect 14(9):828–834

    Article  CAS  PubMed  Google Scholar 

  26. Tsai CJ, Griffin MR, Nuorti JP et al (2008) Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 46(11):1664–1672

    Article  PubMed  Google Scholar 

  27. Tyrell GJ, Lovgren M, Chui N et al (2009) Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006. Vaccine 27(27):3553–3560

    Article  Google Scholar 

  28. Van Ackere T, Proesmans M, Vermeulen F et al (2009) Complicated parapneumonic effusion in Belgian children: increased occurrence before routine pneumococcal vaccine implementation. Eur J Pediatr 168:51–58

    Article  PubMed  Google Scholar 

  29. Van Gils EJ, Veenhoven RH, Hak E et al (2009) Effect of reduced-dose schedules with a 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized control trial. JAMA 302(2):159–167

    Article  PubMed  Google Scholar 

  30. Whitney CG, Farley MM, Hadler J et al (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348(18):1737–1746

    Article  PubMed  Google Scholar 

  31. Winther TN, Kristensen TD, Kaltoft MS et al (2008) Invasive pneumococcal disease in Danish children, 1996–2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine. Acta Paediatr 98(2):328–331

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflicts of interests to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dawn S. Hartfield.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chibuk, T.K., Robinson, J.L. & Hartfield, D.S. Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7). Eur J Pediatr 169, 1123–1128 (2010). https://doi.org/10.1007/s00431-010-1195-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-010-1195-6

Keywords

Navigation